From: Sepsis and obesity: a scoping review of diet-induced obesity murine models
Authors | Method of sepsis | Route of infection | Dose | Endpoint (h) | Antibiotics | Fluids | Analgesia |
---|---|---|---|---|---|---|---|
DeMartini [24] | CLP | IP | Double puncture; 22G | 6 | Imipenem (25 mg/kg) | Sterile saline, SC; (0.6 mL) | NR |
Frydrych [25] | CLP | IP | Double puncture; 20G | 28 days | NR | NR | NR |
Gomes [26] | CLP | IP | Single puncture; 21G | 7 days | NR | Sterile saline, SC; (0.5 mL/10 g) | NR |
Goosses [27] | CLP | IP | Needle not specified | 1, 5 days | Yesa | Yesa, IV | Yesa |
Kaplan [28] | CLP | IP | Double puncture; 21G | 1–30 | NR | Sterile saline, SC; (0.6 mL) | NR |
Kaplan [29] | CLP | IP | Double puncture; 22G | 6 | NR | Sterile saline, SC; (0.6 mL) | NR |
Khan [30] | CLP | IP | Single puncture; 18G | 6 | NR | LR, SC before surgery; (2 mL) LR, IVb and 4 h later | Yesa |
Lewis [31] | CS | IP | 500 μL of CS in 10% glycerol | 14 days | NR | NR | NR |
Panpetch [32] | CLP | IP | Double puncture; 21G | 24 | NR | NR | Fentanyl, SCb and 6 h; (0.03 mg/kg) |
Rivera [33] | CLP | IP | Triple puncture; 20G | 6 | NR | Salineb; (1 mL) | NR |
Siegl [34] | CLP | IP | Single puncture; 23G | 10 days | NR | Sterile saline, SCb; (1 mL) | NR |
Souza [35] | CLP | IP | NR | 24 | NR | NR | NR |
Strandberg [36] | S. aureus | IV | 5 × 107 CFU | 24, 5–7 or 17 days | NR | NR | NR |
Su [37] | CLP | IP | Single puncture; 23G | 12, 24 | NR | Sterile saline, SCb; (4 mL/kg) | 0.25% bupivacaine; (100 µL) |
Vankrunkelsven [38] | CLP | IP | 18G | 5 days | Imipenem/Cilastatin | IVa | Buprenorphine |
Williamson [39] | CLP | IP | Double puncture; 22G | 18 | Imipenem (25 mg/kg) | Normal saline, SC; (1 mL) | NR |
Yeh [40] | CLP | IP | Single puncture; 23G | 12, 24 | NR | Sterile saline, SCb; (4 mL/kg BW) | 0.25% bupivacaine; (100 µL) |